DBV Technologies SA (DBV)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

€3.21

Buy

€3.25

arrow-down€-0.23 (-6.67%)

Prices updated at 12 Dec 2025, 16:35 CET

Prices minimum 15 mins delay

Prices in EUR

DBV Technologies SA is a biopharmaceutical company. It is engaged in research and development of patient-friendly therapy for food and pediatric allergy patients.

FTSE EuroFirst 300

-0.53%

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Biotechnology

Chairman

Mr. Michel De Rosen

CEO

Mr. Daniel Tasse

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

117

Head office

107 Avenue de la Republique

Paris

France

92320

+33 155427878

investors@dbv-technologies.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Dr. Philina Lee, PhD Director	-
Mr. Timothy E. Morris Independent Director	0.13m
Mr. Michel De Rosen Non-Executive Chairman of the Board	0.17m
Ms. Julie O'Neill Independent Director	0.12m
Mr. Michael J. Goller Director	0.12m
Ms. Mailys Ferrere Director	-
Mr. Daniel Tasse Director and Chief Executive Officer	0.60m
Dr. Pharis Mohideen, M.D. Chief Medical Officer	0.57m
Dr. Adora Ndu, Pharm.D. Independent Director	0.11m
Dr. Ravi Madduri Rao, M.D. Independent Director	0.11m
Ms. Daniele Guyot-Caparros Independent Director	0.12m
Ms. Virginie Boucinha Chief Financial Officer and Principal Accounting Officer	0.32m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
CPR Asset Management	810,657
CPR Ambition France	810,657
Alphajet Fair Investors	170,000
Alphajet Europe Microcap	170,000
Generali Asset Management S.p.A. Società di gestione del risparmio	100,000

Director dealings

Date chevron-l-regular chevron-r-regular	Action
22 Nov 2024	-
25 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
29 Jul 2024	-
24 May 2024	-
22 May 2024	-
06 Feb 2024	-
21 Nov 2025	-
21 Nov 2025	-
21 Nov 2025	-
21 Nov 2025	-
21 Nov 2025	-
20 Nov 2025	-
21 Nov 2025	-
21 Nov 2025	-
29 Jul 2025	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.